TeleCare Spot review
Publishes per-program floors — from $299 semaglutide, from $399 tirzepatide — then adds a $79 consultation fee that is only "may be applied" toward treatment, and never names its operating company.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
TeleCare Spot at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $399/mo
- Coverage
- Not stated on the site
- Brand-name
- Compounded only
How we scored TeleCare Spot
Each score comes out of TeleCare Spot's published pricing, disclosures and oversight, and the six combine into the 36/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
The headline rate obscures a plan requirement or a hidden step-up.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
Little here is shaped around a mother's week or her life stage.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- telecarespot.com
Semaglutide from $299 and tirzepatide from $399, plus a $79 consultation fee that is only conditionally credited back. Both prices are floors with no published ceiling, and the site never names the company behind it.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $299 | InjectionRead live 2026-08-21 on /weight-loss/: "From $299 /month". ⛔ CORRECTS the 08-17 screening sheet, which recorded only a "$199 to $499 per month" range — the site now publishes per-program rates. |
| Compounded tirzepatide | $399 | InjectionRead live 2026-08-21: "From $399 /month". |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from TeleCare Spot's public disclosures at last review and change often; confirm the current number on TeleCare Spot's own site.
What we like
- Publishes distinct per-program rates rather than one vague range
- Offers a lower-cost phentermine program from $189/month alongside the GLP-1 options
- Intake is a standard IntakeQ form and responded normally when checked
The caveats
- A separate $79 one-time consultation fee, described only as one that MAY be applied toward treatment
- Both GLP-1 prices are prefixed "From" with no published ceiling
- No operating entity named anywhere on the public site
- No state list published
TeleCare Spot for mothers: our verdict
Publishes per-program floors — from $299 semaglutide, from $399 tirzepatide — then adds a $79 consultation fee that is only "may be applied" toward treatment, and never names its operating company. It runs about $299/month — a premium to the category, so the extras have to earn it.
We weigh TeleCare Spot the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What TeleCare Spot actually costs
- Compounded semaglutide — Injection: $299/mo
- Compounded tirzepatide — Injection: $399/mo
For context, the typical ongoing price across our roster is around $179/month, so TeleCare Spot sits at the premium end.
The medications TeleCare Spot prescribes
TeleCare Spot prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where TeleCare Spot fits — and where it doesn't — for mothers
Worth it if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
TeleCare Spot is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who wants a phentermine option alongside the GLP-1 lane and will confirm whether the $79 consultation fee is actually credited before paying it.
Alternatives to TeleCare Spot
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing TeleCare Spot
Head-to-head & alternatives
TeleCare Spot, answered
- How much does TeleCare Spot cost?
- When we last checked, the cheapest ongoing compounded price at TeleCare Spot was around $299 a month: $299/mo for semaglutide and $399/mo for tirzepatide. Prices here move quickly — confirm today's all-in number on their own site before signing up.
- Is TeleCare Spot safe to use while breastfeeding?
- No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to TeleCare Spot as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
- Does TeleCare Spot offer both semaglutide and tirzepatide?
- Yes — TeleCare Spot offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does TeleCare Spot rank for mothers?
- TeleCare Spot takes 36/100 in our Editors' Rating, placing it #288. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.
Pricing, states and verification reflect TeleCare Spot's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.